Interpace Diagnostics Group Inc (NASDAQ: IDXG) rose 12.9% to $2.87. Interpace Diagnostics reported Q4 earnings from continuing operations of $3.25 per share on revenue of $3.122 million. Share volume was 9.8 million, swamping an all-day average of 1.2 million
